Government has expanded the composition of the committee formed to look into pricing reforms for drugs and medical devices by admitting various industry bodies.
National
According to a circular issued by the Ministry of Chemicals and Fertilisers, Government has expanded the composition of the committee formed to look into pricing reforms for drugs and medical devices by admitting various industry bodies. The committee will now have representation from industry bodies such as the Confederation of Indian Industries (CII), the Organisation of Pharmaceutical Producers of India (OPPI), and the US-India Strategic Partnership Forum (USISPF), among others. The terms of reference of the committee include discussing institutional reforms within the National Pharmaceutical Pricing Authority (NPPA) and ways to balance price and availability of essential medicines, while providing incentives to the industry to sustain growth and exports. In line with this mission, the department has also invited medical device associations such as Medical Technology Association of India (MTaI) and Association of Medical Device Industry (AIMED) to be part of the committee and present the views of the medtech industry.
National Pharmaceutical Pricing Authority (NPPA)
Founded- 29 August 1997; HQ- New Delhi
Chairman- Kamlesh Kumar Pant
____________________________
